These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1242 related items for PubMed ID: 28126014
1. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice. Tada R, Muto S, Iwata T, Hidaka A, Kiyono H, Kunisawa J, Aramaki Y. BMC Res Notes; 2017 Jan 26; 10(1):68. PubMed ID: 28126014 [Abstract] [Full Text] [Related]
2. Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice. Tada R, Hidaka A, Iwase N, Takahashi S, Yamakita Y, Iwata T, Muto S, Sato E, Takayama N, Honjo E, Kiyono H, Kunisawa J, Aramaki Y. PLoS One; 2015 Jan 26; 10(10):e0139785. PubMed ID: 26440657 [Abstract] [Full Text] [Related]
3. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice. Tada R, Suzuki H, Takahashi S, Negishi Y, Kiyono H, Kunisawa J, Aramaki Y. Int Immunopharmacol; 2018 Aug 26; 61():385-393. PubMed ID: 29945026 [Abstract] [Full Text] [Related]
4. Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses. Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstrøm T, Agger EM, Andersen P, Perrie Y. Mol Pharm; 2011 Feb 07; 8(1):153-61. PubMed ID: 21117621 [Abstract] [Full Text] [Related]
5. Cationic DDA/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity. Qu W, Li N, Yu R, Zuo W, Fu T, Fei W, Hou Y, Liu Y, Yang J. Artif Cells Nanomed Biotechnol; 2018 Feb 07; 46(sup1):852-860. PubMed ID: 29447484 [Abstract] [Full Text] [Related]
6. Intranasal administration of cationic liposomes enhanced granulocyte-macrophage colony-stimulating factor expression and this expression is dispensable for mucosal adjuvant activity. Tada R, Hidaka A, Kiyono H, Kunisawa J, Aramaki Y. BMC Res Notes; 2018 Jul 13; 11(1):472. PubMed ID: 30005702 [Abstract] [Full Text] [Related]
7. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution. Zhuang Y, Ma Y, Wang C, Hai L, Yan C, Zhang Y, Liu F, Cai L. J Control Release; 2012 Apr 10; 159(1):135-42. PubMed ID: 22226776 [Abstract] [Full Text] [Related]
8. Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines. Joseph A, Louria-Hayon I, Plis-Finarov A, Zeira E, Zakay-Rones Z, Raz E, Hayashi T, Takabayashi K, Barenholz Y, Kedar E. Vaccine; 2002 Sep 10; 20(27-28):3342-54. PubMed ID: 12213404 [Abstract] [Full Text] [Related]
9. Liposome-mediated DNA immunisation via the subcutaneous route. Perrie Y, McNeil S, Vangala A. J Drug Target; 2003 Sep 10; 11(8-10):555-63. PubMed ID: 15203925 [Abstract] [Full Text] [Related]
10. Role of Interleukin-6 in the Antigen-Specific Mucosal Immunoglobulin A Responses Induced by CpG Oligodeoxynucleotide-Loaded Cationic Liposomes. Tada R, Honjo E, Muto S, Takayama N, Kiyono H, Kunisawa J, Negishi Y. Membranes (Basel); 2022 Jun 20; 12(6):. PubMed ID: 35736342 [Abstract] [Full Text] [Related]
11. Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN. Mansourian M, Badiee A, Jalali SA, Shariat S, Yazdani M, Amin M, Jaafari MR. Immunol Lett; 2014 Nov 20; 162(1 Pt A):87-93. PubMed ID: 25086399 [Abstract] [Full Text] [Related]
12. Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation. Rattanakiat S, Nishikawa M, Takakura Y. Eur J Pharm Sci; 2012 Sep 29; 47(2):352-8. PubMed ID: 22771546 [Abstract] [Full Text] [Related]
13. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice. Ebrahimian M, Hashemi M, Maleki M, Abnous K, Hashemitabar G, Ramezani M, Haghparast A. Int J Pharm; 2016 Dec 30; 515(1-2):708-720. PubMed ID: 27989827 [Abstract] [Full Text] [Related]
14. Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels. Reidel IG, Curti CC, Dorémus L, Béré E, Delwail A, Russi RC, Lecron JC, Morel F, García MI, Müller DM, Jégou JF, Veaute CM. Vaccine; 2024 Mar 19; 42(8):1953-1965. PubMed ID: 38378388 [Abstract] [Full Text] [Related]
15. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution. McCluskie MJ, Weeratna RD, Davis HL. Mol Med; 2000 Oct 19; 6(10):867-77. PubMed ID: 11126201 [Abstract] [Full Text] [Related]
16. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets. Linghua Z, Xingshan T, Fengzhen Z. Vaccine; 2008 Jan 10; 26(2):224-33. PubMed ID: 18063448 [Abstract] [Full Text] [Related]
17. Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice. Moran MC, Bence AR, Vallecillo MFS, Lützelschwab CM, Rodriguez MG, Pardo R, Goldbaum FA, Zylberman V, Palma SD, Maletto BA, Estein SM. Res Vet Sci; 2021 Mar 10; 135():217-227. PubMed ID: 33631456 [Abstract] [Full Text] [Related]
18. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. McCluskie MJ, Weeratna RD, Payette PJ, Davis HL. FEMS Immunol Med Microbiol; 2002 Feb 18; 32(3):179-85. PubMed ID: 11934561 [Abstract] [Full Text] [Related]
19. Endosomal translocation of CpG-oligodeoxynucleotides inhibits DNA-PKcs-dependent IL-10 production in macrophages. Yotsumoto S, Saegusa K, Aramaki Y. J Immunol; 2008 Jan 15; 180(2):809-16. PubMed ID: 18178819 [Abstract] [Full Text] [Related]
20. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen. Mutwiri G, Benjamin P, Soita H, Babiuk LA. Vaccine; 2008 May 23; 26(22):2680-8. PubMed ID: 18430493 [Abstract] [Full Text] [Related] Page: [Next] [New Search]